Molecular alterations underlying eosinophilic and mast cell malignancies.
Hossein Sadrzadeh(Boston University), Amir Fathi(Massachusetts General Hospital), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center)
PubMed
December 1, 2011
Cited by 8
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k